| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/11/2013 | WO2013006730A3 Biological methods for preparing a fatty dicarboxylic acid |
| 04/11/2013 | WO2012170438A3 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO A COMPLEX COMPRISING β-KLOTHO AND AN FGF RECEPTOR |
| 04/11/2013 | WO2012130221A3 Means for treating microbial diseases in cultivated plants |
| 04/11/2013 | WO2007056907A9 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130090455 Transformant which produces glycine repeat sequence protein |
| 04/11/2013 | US20130090376 Antibodies to tumor associated proteins |
| 04/11/2013 | US20130090293 Protein scaffolds for targeted delivery of toxic iron to cancer cells |
| 04/11/2013 | US20130090290 BMP-2 Peptides and Methods of Use |
| 04/11/2013 | US20130090286 Glucagon/glp-1 receptor co-agonists |
| 04/11/2013 | US20130090263 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 04/11/2013 | US20130090251 Tumour Markers |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089893 MULTIMERIC Fc RECEPTOR POLYPEPTIDES |
| 04/11/2013 | US20130089882 Chloroacetamidine Based Inhibitors and Activity Based Probes for the Protein Arginine Methytransferases |
| 04/11/2013 | US20130089867 Isoforms of the human sst5 receptor originated by alternative splicing and oligonucleotide pairs to detect them by pcr |
| 04/11/2013 | US20130089853 Fluorescent dyes |
| 04/11/2013 | US20130089567 Development of dengue virus vaccine components |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089548 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 04/11/2013 | US20130089545 Novel compounds and their effects on feeding behaviour |
| 04/11/2013 | US20130089517 Homogeneous preparations of il-28 and il-29 |
| 04/11/2013 | US20130089513 Method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 04/11/2013 | US20130089503 Light-Sensitive Ion-Passing Molecules |
| 04/11/2013 | US20130089500 Antagonists of ligands and uses thereof |
| 04/11/2013 | US20130089499 Antagonists of ligands and uses thereof |
| 04/11/2013 | DE112010001777T5 Verwendung von silintaphin für die struktur-gerichtete herstellung von (nano)composit-materialien in medizin und (nano)technologie Use of silintaphin for the structure-directed production of (nano) materials in medicine-composit and (nano) technology |
| 04/11/2013 | DE102011105694A1 Zelluläre Proteine ("host-factors"), die essenziell sind für die Vermehrung von RNA-Viren Cellular proteins ("host factors"), which are essential for the replication of RNA viruses |
| 04/11/2013 | CA2851251A1 Simian (gorilla) adenovirus or adenoviral vectors and methods of use |
| 04/11/2013 | CA2850944A1 Human notch1 decoys |
| 04/11/2013 | CA2850668A1 Srm/mrm assay for the ephrin type-a receptor 2 protein |
| 04/11/2013 | CA2850629A1 Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| 04/11/2013 | CA2850627A1 Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| 04/11/2013 | CA2850274A1 Ecm composition, tumor microenvironment platform and methods thereof |
| 04/11/2013 | CA2849856A1 Regulatable promoter |
| 04/11/2013 | CA2843520A1 Fibroblast growth factor 21 variants |
| 04/11/2013 | CA2835074A1 Pure albumin and a method of producing and detecting it |
| 04/10/2013 | EP2578684A1 Antagonists of ligands and uses thereof |
| 04/10/2013 | EP2578678A1 Method for producing tumor cell |
| 04/10/2013 | EP2578599A1 Cyclic analogs of GLP-1 and GLP-1 related peptides |
| 04/10/2013 | EP2578224A1 Cell growth-promoting peptide and use thereof |
| 04/10/2013 | EP2577315A1 Markers for renal disease |
| 04/10/2013 | EP2576813A1 Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents |
| 04/10/2013 | EP2576790A1 Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | EP2576773A2 Methods and helper viruses for the generation of rna virus |
| 04/10/2013 | EP2576624A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
| 04/10/2013 | EP2576615A2 Fibronectin based scaffold proteins having improved stability |
| 04/10/2013 | EP2576614A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis |
| 04/10/2013 | EP2576613A1 Her-2 peptides and vaccines |
| 04/10/2013 | EP2576612A1 Insulin analogues |
| 04/10/2013 | EP2576611A2 Sulfation of wnt pathway proteins |
| 04/10/2013 | EP2576610A2 Biomarker for diagnosis and treatment of colorectal cancer |
| 04/10/2013 | EP2576609A1 Epitope tag for affinity-based applications |
| 04/10/2013 | EP2576608A1 Fraction of proteins and peptides derived from egg white and protein derived from egg white and use thereof as anti-listeria agent |
| 04/10/2013 | EP2576607A1 Means for the transient production in plants of recombinant proteins that can be used in particular in prophylaxis and in therapeutics |
| 04/10/2013 | EP2576606A1 C4 dicarboxylic acid production in filamentous fungi |
| 04/10/2013 | EP2576605A2 Production of metabolites |
| 04/10/2013 | EP2576604A1 Diffocins and methods of use thereof |
| 04/10/2013 | EP2576603A1 Methods and strains for the production of sarcinaxanthin and derivatives thereof |
| 04/10/2013 | EP2576602A1 Chimeric momp antigen, method and use |
| 04/10/2013 | EP2576601A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceæ family, having attenuated expression of genes encoding a lysine/arginine/ornithine transporter |
| 04/10/2013 | EP2576600A1 Novel 7alpha-hydroxysteroid dehydrogenase knockout mutants and use thereof |
| 04/10/2013 | EP2576599A1 A genetically modified bacterium of the species listeria monocytogenes |
| 04/10/2013 | EP2576597A1 Rhamm binding peptides |
| 04/10/2013 | EP2576593A1 Methods for the synthesis of dicarba bridges in peptides |
| 04/10/2013 | EP2576579A2 Compositions and methods directed to treating liver fibrosis |
| 04/10/2013 | EP2575909A1 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof |
| 04/10/2013 | EP2575875A1 An immunogenic composition for treatment of hepatitis c, a method for preparing the composition and use thereof for treating hepatitis c |
| 04/10/2013 | EP2575874A1 Lactadherin-derived peptides as antiviral agents |
| 04/10/2013 | EP2575864A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases |
| 04/10/2013 | EP2575862A2 Neuregulin isoforms, neuregulin polypeptides and uses thereof |
| 04/10/2013 | EP2575852A1 Antimicrobial peptides and peptide derivatives derived from oncopeltus fasciatus |
| 04/10/2013 | EP2575850A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 04/10/2013 | EP2575846A1 Insulin-like growth factor 1 receptor binding peptides |
| 04/10/2013 | EP2575439A1 Fusion proteins comprising a dna-binding domain of a tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| 04/10/2013 | EP2575430A1 Plants with increased fruit size |
| 04/10/2013 | EP2575429A1 Method for increasing plant biomass |
| 04/10/2013 | CN103038351A Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | CN103038344A Fc binding protein and method for producing same |
| 04/10/2013 | CN103038253A Peptides as active agents to stabilize biological barriers |
| 04/10/2013 | CN103038252A Improved complement receptor 2 (CR2) targeting groups |
| 04/10/2013 | CN103038251A Novel ctla4-ig immunoadhesins |
| 04/10/2013 | CN103038250A 胰高血糖素类似物 Glucagon analogs |
| 04/10/2013 | CN103038249A Tear lipocalin in muteins binding Il-4 R alpha |
| 04/10/2013 | CN103038248A RHAMM binding peptides |
| 04/10/2013 | CN103037897A Lactadherin-derived peptides as antiviral agents |
| 04/10/2013 | CN103037893A Treatment of coagulopathy with hyperfibrinolysis |
| 04/10/2013 | CN103037890A Dendritic cell inhibitory proteins from ticks |
| 04/10/2013 | CN103037840A Lipid membrane structure with nuclear transferability |
| 04/10/2013 | CN103037683A Method for increasing plant biomass |
| 04/10/2013 | CN103033617A Tumor marker detection kit based on variable lymphocyte receptors and method for preparing same |
| 04/10/2013 | CN103031310A Expression of proteins in plants |
| 04/10/2013 | CN103031309A Clone, expression and application of antimicrobial protein HAS1 encoding gene |
| 04/10/2013 | CN103031277A Application of mechano-growth factor in preparation of serum-free cultured tolerant type mammal engineering cell |
| 04/10/2013 | CN103030979A Collagen antibacterial membrane containing cinnamon essential oil and preparation method of collagen antibacterial membrane |
| 04/10/2013 | CN103030978A Fish scale collagen/ pullulan composite edible membrane and preparation method thereof |
| 04/10/2013 | CN103030693A Neutralization molecule of high-pathogenicity avian influenza and preparation method thereof |